Timothy Synold, Pharm.D., is a clinical and molecular pharmacologist who serves as director of the Analytical Pharmacology Laboratory. He is also the scientific leader of the City of Hope Phase I Clinical Trial team and director of Pharmacology for the NCI-supported California Cancer Consortium. Dr. Synold has over 25 years experience in chemistry and pharmacology, and he is an expert in the fields of pharmacokinetics and pharmacodynamics. His current research focus involves the role of the blood-brain-barrier in central nervous system penetration of drugs.